AbbVie at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

AbbVie takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8034. Its program centres on ovarian cancer and the move towards personalised treatment built on recent advances.

OrganizationESMO 2026 Attendance
AbbVie
North Chicago, IL
abbvie.com
Large pharmaExhibitor
Global biopharmaceutical company with oncology medicines including venetoclax, ibrutinib and antibody-drug conjugates.
Booth
Exhibiting at Booth 8034
Satellite
Fri Oct 23
09:45–11:15
AbbVie - Riding the Wave of Innovation Towards Personalized Medicine in Ovarian Cancer
Sponsored session · with Hospital Universitario Puerta de Hierro Majadahonda
Gynaecological cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AbbVie

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction